Funding for this research was provided by:
National Institute on Minority Health and Health Disparities (1R01MD009675, 1R01MD009675, 1R01MD009675, 1R01MD009675)
St. David’s Foundation
Received: 21 July 2021
Accepted: 16 September 2022
First Online: 17 October 2022
: The institutional review boards of the University of Texas at Austin, Baylor College of Medicine, and the University of Kansas Medical Center approved the study, and all study participants provided written informed consent to participate in the study. No adverse study-related events were reported. The randomized clinical trial and all analysis methods were implemented in accordance with the relevant guidelines and regulations of the U.S. National Institute on Health.
: Not applicable.
: The authors declare that they have no competing interest.